Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines

Spectrum of Activity and Mechanisms of Resistance of Various Nucleoside Derivatives against Gammaherpesviruses

(2014) Natacha Coen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders

(2014) Sanghui Park et al.   JOURNAL OF DERMATOLOGY

Current research on chronic active Epstein-Barr virus infection in Japan

(2014) Shigeyoshi Fujiwara et al.   PEDIATRICS INTERNATIONAL

Autocrine CCL3 and CCL4 Induced by the Oncoprotein LMP1 Promote Epstein-Barr Virus-Triggered B Cell Proliferation

(2013) S.-C. Tsai et al.   JOURNAL OF VIROLOGY

Application of flow cytometricin situhybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases

(2012) Shinji Kawabe et al.   CANCER SCIENCE

Cutaneous EBV-positive γδ T-cell lymphoma vs. extranodal NK/T-cell lymphoma: a case report and literature review

(2012) Wei-Wen Yu et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF- B Activation

(2012) A. M. Price et al.   JOURNAL OF VIROLOGY

Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis

(2012) Yoshinori Ito et al.   PEDIATRIC BLOOD & CANCER

Genomic Sequencing and Comparative Analysis of Epstein-Barr Virus Genome Isolated from Primary Nasopharyngeal Carcinoma Biopsy

(2012) Hin Kwok et al.   PLoS One

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

(2011) J. I. Cohen et al.   BLOOD

C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7

(2011) Laila Cancian et al.   PLoS Pathogens

Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH

(2010) S. Calattini et al.   BLOOD

Endogenous latent membrane protein 1 in Epstein–Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines

(2010) Hsiao-Ching Lai et al.   VIROLOGY

Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2

(2008) W. Lucchesi et al.   JOURNAL OF VIROLOGY

Epstein-Barr virus: a paradigm for persistent infection – for real and in virtual reality

(2008) David A. Thorley-Lawson et al.   TRENDS IN IMMUNOLOGY